# 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer

> **NCT04857502** · EARLY_PHASE1 · RECRUITING · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 30 (estimated)

## Conditions studied

- Prostate Carcinoma
- Recurrent Prostate Carcinoma

## Interventions

- **DRUG:** 99mTc-based PSMA Imaging and Surgery Agent
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Single Photon Emission Computed Tomography

## Key facts

- **NCT ID:** NCT04857502
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-27
- **Primary completion:** 2026-06-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04857502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04857502, "99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04857502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*